Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 20, Number 4—April 2014

Dispatch

Salmonella Subtypes with Increased MICs for Azithromycin in Travelers Returned to the Netherlands

Robert-Jan HassingComments to Author , Wil H.F. Goessens, Wilfrid van Pelt, Dik J. Mevius, Bruno H. Stricker, Nicky Molhoek, Annelies Verbon, and Perry J.J. van Genderen
Author affiliations: Erasmus Medical Centre, Rotterdam, the Netherlands (R.-J. Hassing, W.H.F. Goessens, B.H. Stricker, A. Verbon); Inspectorate of Health Care, The Hague, the Netherlands (R.-J. Hassing, B.H. Stricker); National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands (W. van Pelt); Utrecht University, Utrecht, the Netherlands (D.J. Mevius); Central Veterinary Institute of Wageningen UR, Lelystad, the Netherlands (D.J. Mevius); Travel Clinic Havenziekenhuis, Rotterdam (N. Molhoek, P.J.J. van Genderen); Institute for Tropical Diseases, Havenziekenhuis, Rotterdam (P.J.J. van Genderen)

Main Article

Figure 2

MICs of azithromycin in relation to ciprofloxacin susceptibility of 354 Salmonella enterica serotypes Typhi and Paratyphi isolates. Increased MICs for azithromycin (MIC>16 μg/mL) in isolates with decreased ciprofloxacin susceptibility or ciprofloxacin resistance (MIC>0.125 μg/mL) versus ciprofloxacin-susceptible isolates (MIC<0.125 μg/mL) (p = 0.004).

Figure 2. . MICs of azithromycin in relation to ciprofloxacin susceptibility of 354 Salmonella enterica serotypes Typhi and Paratyphi isolates. Increased MICs for azithromycin (MIC>16 μg/mL) in isolates with decreased ciprofloxacin susceptibility or ciprofloxacin resistance (MIC>0.125 μg/mL) versus ciprofloxacin-susceptible isolates (MIC<0.125 μg/mL) (p = 0.004).

Main Article

TOP